Christopher Edlund is the Director of Technology Bioinformatics at Illumina, leading teams to advance next-generation sequencing (NGS) and multiomics technologies. With an M. S. from Chalmers University of Technology, his expertise spans the full innovation lifecycle, from early-stage research to clinical product development, particularly in oncology.
He previously managed the Bioinformatics Core at USCs Norris Comprehensive Cancer Center, overseeing massive whole-genome sequencing and GWAS projects.
Read the full overview →They are more likely than others to negotiate on pricing and terms. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They prefer to do thorough analysis of any situation.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.